11-66473290-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145065.3(PELI3):āc.506C>Gā(p.Ser169Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000775 in 1,613,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145065.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PELI3 | NM_145065.3 | c.506C>G | p.Ser169Cys | missense_variant | 6/8 | ENST00000320740.12 | NP_659502.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PELI3 | ENST00000320740.12 | c.506C>G | p.Ser169Cys | missense_variant | 6/8 | 1 | NM_145065.3 | ENSP00000322532 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000957 AC: 24AN: 250730Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135572
GnomAD4 exome AF: 0.0000746 AC: 109AN: 1461222Hom.: 0 Cov.: 30 AF XY: 0.0000757 AC XY: 55AN XY: 726934
GnomAD4 genome AF: 0.000105 AC: 16AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | The c.506C>G (p.S169C) alteration is located in exon 6 (coding exon 5) of the PELI3 gene. This alteration results from a C to G substitution at nucleotide position 506, causing the serine (S) at amino acid position 169 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at